期刊文献+

EORTC QLQ-BM22在评价中国癌症骨转移病人生活质量中的有效性研究 被引量:14

Study on effectiveness of EORTC QLQ-BM22 in evaluating quality of life of cancer patients with bone metastasis in China
下载PDF
导出
摘要 [目的]验证欧洲癌症研究与治疗组织的生活质量骨转移量表(EORTC QLQ-BM22)测定中国癌症骨转移病人生活质量的信度、效度及可接受性。[方法]采用EORTC QLQ-BM22问卷对2013年6月—2013年11月在天津市肿瘤医院内科病房接受治疗的121例癌症骨转移病人进行问卷调查,一次性完成欧洲癌症研究与治疗组织的生活质量核心量表(EORTC QLQ-C30)和EORTC QLQ-BM22,并进行KPS评分,对结果采用Cronbach’sα系数、Pearson相关检验及Wilcoxon秩和检验进行统计分析。[结果]4个领域的内部一致性均得到确认;EORTC QLQ-BM22与EORTCQLQ-C30之间具有足够的相关性,但二者存在一定差异;4个领域在不同KPS分组(KPS≤80;KPS>80)中的差异有统计学意义(P<0.05);量表依从性较高。[结论]中国本土化的EORTC QLQBM22具有可靠性、有效性和可接受性,可用于评价中国癌症骨转移病人的生活质量。 Objective:To verify the reliability,validity and acceptability of EORTC QLQ-BM22 in assessment of quality of life of cancer patients with bone metastasis in China.Methods:EORTC QLQ-BM22 questionnaire was used to investigate 121 cancer patients with bone metastasis treated in department of internal medicine in Tianjin cancer hospital from June 2013 to November 2013.The EORTC QLQ-C30 and EORTC QLQ-BM22 at one time were and to do completed KPS score.Statistical analysis of the results was carried out by using Cronbach's alpha coefficient,Pearson correlation analysis and Wilcoxon rank-sum test.Results:The internal consistency of the 4fields was confirmed.EORTC QLQ-BM22 and EORTC QLQ-C30 had enough correlation,but there were some differences between them.4fields in different KPS groups(KPS≤80;KPS80)had statistical significant difference(P〈0.05).The compliance of the scale was higher.Conclusion:The localization of EORTC QLQBM22 in China has the reliability,validity and acceptability.It can be used to evaluate the quality of life of cancer patients with bone metastasis in China.
出处 《护理研究(中旬版)》 2015年第9期3244-3247,共4页 Chinese Nursing Researsh
关键词 骨转移 癌症 生活质量 欧洲癌症研究与治疗组织的生活质量骨转移量表 bone metastasis cancer quality of life EORTC QLQ-BM22
  • 相关文献

参考文献14

  • 1Mundy GR. Metastasis to bone: Causes, consequences and thera-peutic opportunities[J], Nat Rev Cancer,2002,2 : 584 - 593.
  • 2Chow E, Hird A,Velikova G,etal. The European Organization forResearch and Treatment of Cancer Quality of Life Questionnairefor patients with bone metastases:The EORTC QLQ - BM22[J].Eur J Cancer,2009,45C7):1146 - 1152.
  • 3Chow E, Nguyen J, Zhang L,etal. International field testing of thereliability and validity of the EORTC QLQ - BM22 module to as-sess health - related quality of life in patients with bone metasta-ses[J]. Cancer, 2012,118(5):1457 - 1465.
  • 4Satoh T, Kobayashi K, Hori T,et al. The European Organisationfor Research and Treatment of Cancer (EORTC) Quality of LifeQuestionnaire for Japanese patients with bone metastases - theJapanese version of the EORTC QLQ-BM22[J]. Gan To KagakuRyoho,2010,37(8):1507 - 1512.
  • 5Pusklilluogla M,Tomaszewski KA,Bottomley A,et al. Validationof the polish version of the EORTC QLQ - BM22 module for theassessment of health - related quality of life in patients with bonemetastases[J]. Qual Life Res,2013,3:239 - 254.
  • 6Zeng Chow E, Zhang L, et al. An international prospective studyestablishing minimal clinically important differences in theEORTC QLQ - BM22 and QLQ - C30 in cancer patients withbone metastases[J], Support Care Cancer, 2012 , 20 ( 12) : 3307 -3313.
  • 7Zeng L,Chow E,Bedard G,et al. Quality of life after palliative ra-diation therapy for patients with painful bone metastases : Resultsof an international study validating the EORTC QLQ - BM22[J].Int J Radiat Oncol Biol Phys, 2012 .84(3) : 337 - 342.
  • 8Kurosaka S, Satoh T, Chow E, et a/.'EORTC QLQ - BM22 andQLQ - C30 quality of life scores in patients with painful bone me-tastases of prostate cancer treated with strontium - 89 radionu-clide therapy[J]. Ann Nucl Med,2012,26(6):485 - 491.
  • 9Payers PM, Aaronson NK,Bjordal K,et al. The EORTC QLQC30scoring manual[M], 3rd ed. Brussels Belgium:European Organiza-tion for Research and Treatment of Cancer,2001 : 1.
  • 10Montazeri A, Gillis CR, McEwen J. Quality of life in patientswith lung cancer: A review of literature from 1970 to 1995[J].Chest,1998,113:467 - 481.

二级参考文献5

  • 1D. Osoba,N.K. Aaronson,M. Muller,K. Sneeuw,M.-A. Hsu,W.K.A. Yung,M. Brada,E. Newlands. Effect of neurological dysfunction on health-related quality of life in patients with high-grade glioma[J] 1997,Journal of Neuro - Oncology(3):263~278
  • 2D. Osoba,B. Zee,J. Pater,D. Warr,L. Kaizer,J. Latreille. Psychometric properties and responsiveness of the EORTC Quality of Life Questionnaire (QLQ-C30) in patients with breast, ovarian and lung cancer[J] 1994,Quality of Life Research(5):353~364
  • 3C. A. C. Schag,P. A. Ganz,D. S. Wing,M. -S. Sim,J. J. Lee. Quality of life in adult survivors of lung, colon and prostate cancer[J] 1994,Quality of Life Research(2):127~141
  • 4H. E. Niezgoda,J. L. Pater. A validation study of the domains of the core EORTC Quality of Life Questionnaire[J] 1993,Quality of Life Research(5):319~325
  • 5V. Sigurdardóttir,C. Bolund,Y. Brandberg,M. Sullivan. The impact of generalized malignant melanoma on quality of life evaluated by the EORTC questionnaire technique[J] 1993,Quality of Life Research(3):193~203

共引文献379

同被引文献153

引证文献14

二级引证文献101

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部